Statistically, the incidence of thyroid cancer has increased worldwide over the past few decades, but researchers are unsure if it's an uptick in the prevalence of thyroid cancer or an increase in detection. A new clinical trial aims to ...
When Type 2 diabetes is the diagnosis, physicians rarely think chronic pancreatitis is the cause. However, chronic pancreatitis may be more prevalent than many doctors think. Investigators at Cedars-Sinai are part of multicenter trials ...
Jane Figueiredo, PhD, heads the nation’s largest study on prevention and treatment of colorectal cancer in Latino people. Here, she shares revelations that drive her commitment to fighting cancer disparities in underserved populations.
Laughter may be the best medicine. The director of Cedars-Sinai's Cancer Rehabilitation and Survivorship program, Arash Asher, MD, helped create an improv comedy class and is evaluating its benefits to patients.
Scientists at Cedars-Sinai look to pinpoint genes tied to increased ovarian cancer risk. They hope the findings will help identify ways to prevent ovarian cancer from progressing to late, lethal stages.
The usually harmless human papillomavirus (HPV) is triggering a surge of throat cancer among Baby Boomers. Two Cedars-Sinai investigators are working to ease the burden of treatment on the population most at risk: older men.
Every day, about 1,300 people around the world are diagnosed with pancreatic cancer. At Cedars-Sinai, clinicians are taking novel approaches not only to attack the disease, but to improve patients' quality of life during treatment.
Kameron Sharpe was first diagnosed with cancer at 8 years old. Now 15, he's battling his third recurrence of the disease with a new investigational medication to help future pediatric patients dealing with similar cancers.
Cultural barriers once kept Myong Shim Lee from vital healthcare services—and such obstacles remain in place in many under-served communities. Now, Cedars-Sinai investigators are opening lines of communication to help more people get ...
Genetic counselor John Lee, MS, of the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, discusses game-changing advances related to genes, the proactive power of DNA testing—and why consumers may be buying bad science.